COWEALTH MEDICAL CHINA CO.,LTD. Financials Cowealth Medical China Co.,Ltd.
Equities
603122
CNE100005R39
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.52 CNY | +0.15% |
|
+3.99% | -19.01% |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 4,458 | 3,204 |
| Enterprise Value (EV) 1 | 4,201 | 3,077 |
| P/E ratio | 50.9 x | 67.1 x |
| Yield | 1.34% | 0.75% |
| Capitalization / Revenue | 3.48 x | 2.93 x |
| EV / Revenue | 3.28 x | 2.82 x |
| EV / EBITDA | 39.3 x | 42.6 x |
| EV / FCF | -48.2 x | -42 x |
| FCF Yield | -2.08% | -2.38% |
| Price to Book | 3.79 x | 2.75 x |
| Nbr of stocks (in thousands) | 398,053 | 398,053 |
| Reference price 2 | 11.20 | 8.050 |
| Announcement Date | 3/21/23 | 3/22/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 904.3 | 1,047 | 1,089 | 1,191 | 1,280 | 1,093 |
| EBITDA 1 | 102.5 | 104.1 | 110.5 | 112.7 | 106.9 | 72.21 |
| EBIT 1 | 78.97 | 84.82 | 94.09 | 102 | 98.87 | 65.04 |
| Operating Margin | 8.73% | 8.1% | 8.64% | 8.57% | 7.73% | 5.95% |
| Earnings before Tax (EBT) 1 | 92.67 | 92.56 | 98.57 | 109.5 | 113.8 | 65.7 |
| Net income 1 | 66.91 | 67.14 | 72.55 | 80.23 | 82.72 | 47.19 |
| Net margin | 7.4% | 6.41% | 6.66% | 6.74% | 6.46% | 4.32% |
| EPS | - | 0.2600 | 0.2400 | 0.2700 | 0.2200 | 0.1200 |
| Free Cash Flow 1 | 33.99 | -164.5 | 67.58 | -113.8 | -87.22 | -73.3 |
| FCF margin | 3.76% | -15.71% | 6.21% | -9.55% | -6.82% | -6.71% |
| FCF Conversion (EBITDA) | 33.14% | - | 61.13% | - | - | - |
| FCF Conversion (Net income) | 50.79% | - | 93.15% | - | - | - |
| Dividend per Share | - | 0.2000 | - | 0.1800 | 0.1500 | 0.0600 |
| Announcement Date | 12/31/20 | 12/31/20 | 12/29/21 | 3/21/22 | 3/21/23 | 3/22/24 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 1.74 | 191 | 131 | 15.5 | 257 | 127 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 34 | -164 | 67.6 | -114 | -87.2 | -73.3 |
| ROE (net income / shareholders' equity) | 17.1% | 11.5% | 9.63% | 10.6% | 8.38% | 4.02% |
| ROA (Net income/ Total Assets) | 7.28% | 5.53% | 5.28% | 5.75% | 4.61% | 2.69% |
| Assets 1 | 918.6 | 1,215 | 1,375 | 1,397 | 1,794 | 1,753 |
| Book Value Per Share | - | 2.640 | 2.400 | 2.670 | 2.960 | 2.930 |
| Cash Flow per Share | - | 0.1900 | 0.8300 | 0.4900 | 0.8200 | 0.5000 |
| Capex 1 | 16.4 | 27.8 | 8.11 | 22.1 | 25.9 | 68 |
| Capex / Sales | 1.82% | 2.66% | 0.74% | 1.86% | 2.03% | 6.22% |
| Announcement Date | 12/31/20 | 12/31/20 | 12/29/21 | 3/21/22 | 3/21/23 | 3/22/24 |
1CNY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -19.01% | 359M | |
| -5.97% | 1.39B | |
| -1.95% | 1.42B | |
| -6.88% | 1.2B | |
| -13.47% | 910M | |
| +1.39% | 473M | |
| +3.85% | 441M | |
| -47.20% | 369M | |
| -2.26% | 213M | |
| -29.94% | 203M |
- Stock Market
- Equities
- 603122 Stock
- Financials Cowealth Medical China Co.,Ltd.